Palisade Bio
Price & Volume
Stats
See more52W Range | $0.53-$2.86 |
Market Cap | $359.7M |
Shares Short | 26M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | $0.12 |
News
See moreYahoo Finance • last month
Wolfe Highlights Differentiation Potential in Palisade Bio, Inc. (PALI) Clinical Profile
Yahoo Finance • 2 months ago
Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges
Yahoo Finance • 6 months ago
Palisade Bio Strengthens Clinical Leadership Team with Appointment of James Izanec, MD, AGAF as Vice President, Clinical Development
Yahoo Finance • 6 months ago
Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference
About
CEO | Mr. J. D. Finley |
CFO | Mr. J. D. Finley |
Address | 4600 South Syracuse Street, Denver, CO, United States, 80237 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 14 |